nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—breast cancer	0.458	1	CbGaD
Gadobenate Dimeglumine—ALB—Irinotecan—breast cancer	0.0537	0.402	CbGbCtD
Gadobenate Dimeglumine—ALB—Fluorouracil—breast cancer	0.0515	0.386	CbGbCtD
Gadobenate Dimeglumine—ALB—Methotrexate—breast cancer	0.0284	0.213	CbGbCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—CFL1—breast cancer	9.82e-05	0.00295	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—MTHFR—breast cancer	9.71e-05	0.00292	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—FN1—breast cancer	9.2e-05	0.00276	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—VEGFC—breast cancer	9.19e-05	0.00276	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—ALDOA—breast cancer	9.19e-05	0.00276	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—RAD51B—breast cancer	9.16e-05	0.00275	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—SERPINE1—breast cancer	8.93e-05	0.00268	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—IL1B—breast cancer	8.91e-05	0.00268	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—FN1—breast cancer	8.76e-05	0.00263	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—EGF—breast cancer	8.7e-05	0.00261	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—COX11—breast cancer	8.67e-05	0.0026	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC39A7—breast cancer	8.67e-05	0.0026	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—EGF—breast cancer	8.29e-05	0.00249	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IFNG—breast cancer	8.13e-05	0.00244	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—IGF1—breast cancer	8.06e-05	0.00242	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	8.03e-05	0.00241	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—RELA—breast cancer	8.02e-05	0.00241	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC22A18—breast cancer	7.93e-05	0.00238	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SERPINB2—breast cancer	7.79e-05	0.00234	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—RAD51C—breast cancer	7.79e-05	0.00234	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC2A2—breast cancer	7.78e-05	0.00234	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—TGFB2—breast cancer	7.73e-05	0.00232	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—THBS1—breast cancer	7.7e-05	0.00231	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—breast cancer	7.68e-05	0.00231	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet degranulation—SERPINE1—breast cancer	7.65e-05	0.0023	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLCO1B1—breast cancer	7.63e-05	0.00229	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC2A5—breast cancer	7.63e-05	0.00229	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PDE2A—breast cancer	7.59e-05	0.00228	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—breast cancer	7.29e-05	0.00219	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	7.29e-05	0.00219	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	7.29e-05	0.00219	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IL1B—breast cancer	7.25e-05	0.00218	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—KDM1A—breast cancer	7.24e-05	0.00217	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IL2—breast cancer	7.22e-05	0.00217	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—SERPINE1—breast cancer	7.09e-05	0.00213	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—STIM1—breast cancer	6.94e-05	0.00208	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—HADHB—breast cancer	6.91e-05	0.00208	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC39A6—breast cancer	6.57e-05	0.00197	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—TNF—breast cancer	6.47e-05	0.00194	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IFNG—breast cancer	6.46e-05	0.00194	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—RELA—breast cancer	6.37e-05	0.00191	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—FHL2—breast cancer	6.32e-05	0.0019	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC5A5—breast cancer	6.24e-05	0.00187	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—PTGS2—breast cancer	6.19e-05	0.00186	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PLG—breast cancer	6.11e-05	0.00184	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—F3—breast cancer	6.07e-05	0.00182	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—SLC-mediated transmembrane transport—SLC2A1—breast cancer	6.02e-05	0.00181	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ATP7B—breast cancer	6.01e-05	0.0018	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	5.87e-05	0.00176	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PDGFA—breast cancer	5.8e-05	0.00174	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IL1B—breast cancer	5.76e-05	0.00173	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Mitoxantrone—breast cancer	5.71e-05	0.000153	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Capecitabine—breast cancer	5.71e-05	0.000152	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	5.69e-05	0.00171	CbGpPWpGaD
Gadobenate Dimeglumine—Paraesthesia—Docetaxel—breast cancer	5.66e-05	0.000151	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Gemcitabine—breast cancer	5.65e-05	0.000151	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Doxorubicin—breast cancer	5.64e-05	0.00015	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—ITPR1—breast cancer	5.63e-05	0.00169	CbGpPWpGaD
Gadobenate Dimeglumine—Dyspnoea—Docetaxel—breast cancer	5.62e-05	0.00015	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Docetaxel—breast cancer	5.61e-05	0.00015	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Methotrexate—breast cancer	5.6e-05	0.00015	CcSEcCtD
Gadobenate Dimeglumine—Rash—Gemcitabine—breast cancer	5.6e-05	0.00015	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Gemcitabine—breast cancer	5.6e-05	0.000149	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Epirubicin—breast cancer	5.6e-05	0.000149	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCC1—breast cancer	5.59e-05	0.00168	CbGpPWpGaD
Gadobenate Dimeglumine—Tinnitus—Epirubicin—breast cancer	5.58e-05	0.000149	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Methotrexate—breast cancer	5.57e-05	0.000149	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Methotrexate—breast cancer	5.57e-05	0.000149	CcSEcCtD
Gadobenate Dimeglumine—Headache—Gemcitabine—breast cancer	5.57e-05	0.000149	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Capecitabine—breast cancer	5.56e-05	0.000148	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Epirubicin—breast cancer	5.56e-05	0.000148	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Epirubicin—breast cancer	5.56e-05	0.000148	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Fluorouracil—breast cancer	5.56e-05	0.000148	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Doxorubicin—breast cancer	5.55e-05	0.000148	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Docetaxel—breast cancer	5.55e-05	0.000148	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Doxorubicin—breast cancer	5.51e-05	0.000147	CcSEcCtD
Gadobenate Dimeglumine—Rash—Fluorouracil—breast cancer	5.51e-05	0.000147	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Fluorouracil—breast cancer	5.5e-05	0.000147	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Capecitabine—breast cancer	5.48e-05	0.000146	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Paclitaxel—breast cancer	5.48e-05	0.000146	CcSEcCtD
Gadobenate Dimeglumine—Headache—Fluorouracil—breast cancer	5.47e-05	0.000146	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Doxorubicin—breast cancer	5.47e-05	0.000146	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Doxorubicin—breast cancer	5.46e-05	0.000146	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Methotrexate—breast cancer	5.45e-05	0.000146	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Docetaxel—breast cancer	5.44e-05	0.000145	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Doxorubicin—breast cancer	5.44e-05	0.000145	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Capecitabine—breast cancer	5.44e-05	0.000145	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Docetaxel—breast cancer	5.44e-05	0.000145	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Epirubicin—breast cancer	5.43e-05	0.000145	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Doxorubicin—breast cancer	5.43e-05	0.000145	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Mitoxantrone—breast cancer	5.42e-05	0.000145	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Irinotecan—breast cancer	5.42e-05	0.000145	CcSEcCtD
Gadobenate Dimeglumine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	5.42e-05	0.00163	CbGpPWpGaD
Gadobenate Dimeglumine—Immune system disorder—Epirubicin—breast cancer	5.41e-05	0.000144	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Epirubicin—breast cancer	5.4e-05	0.000144	CcSEcCtD
Gadobenate Dimeglumine—Pain—Docetaxel—breast cancer	5.39e-05	0.000144	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Docetaxel—breast cancer	5.39e-05	0.000144	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Methotrexate—breast cancer	5.39e-05	0.000144	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Capecitabine—breast cancer	5.37e-05	0.000143	CcSEcCtD
Gadobenate Dimeglumine—Chills—Epirubicin—breast cancer	5.37e-05	0.000143	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Epirubicin—breast cancer	5.35e-05	0.000143	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—breast cancer	5.34e-05	0.000142	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Paclitaxel—breast cancer	5.34e-05	0.000142	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Gemcitabine—breast cancer	5.28e-05	0.000141	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Capecitabine—breast cancer	5.27e-05	0.000141	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Capecitabine—breast cancer	5.26e-05	0.00014	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Paclitaxel—breast cancer	5.26e-05	0.00014	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—VEGFA—breast cancer	5.26e-05	0.00158	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Folate Metabolism—TNF—breast cancer	5.26e-05	0.00158	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PLA2G4A—breast cancer	5.26e-05	0.00158	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—HGF—breast cancer	5.26e-05	0.00158	CbGpPWpGaD
Gadobenate Dimeglumine—Mental disorder—Epirubicin—breast cancer	5.25e-05	0.00014	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—GPX2—breast cancer	5.24e-05	0.00157	CbGpPWpGaD
Gadobenate Dimeglumine—Pain—Capecitabine—breast cancer	5.22e-05	0.000139	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Capecitabine—breast cancer	5.22e-05	0.000139	CcSEcCtD
Gadobenate Dimeglumine—ALB—Vitamin B12 Metabolism—IL6—breast cancer	5.22e-05	0.00157	CbGpPWpGaD
Gadobenate Dimeglumine—Malnutrition—Epirubicin—breast cancer	5.21e-05	0.000139	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Epirubicin—breast cancer	5.21e-05	0.000139	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—CSF2—breast cancer	5.2e-05	0.00156	CbGpPWpGaD
Gadobenate Dimeglumine—Feeling abnormal—Docetaxel—breast cancer	5.2e-05	0.000139	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Fluorouracil—breast cancer	5.19e-05	0.000138	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—breast cancer	5.18e-05	0.000138	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—GPX4—breast cancer	5.17e-05	0.00155	CbGpPWpGaD
Gadobenate Dimeglumine—Ill-defined disorder—Methotrexate—breast cancer	5.17e-05	0.000138	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—breast cancer	5.16e-05	0.000138	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Docetaxel—breast cancer	5.16e-05	0.000138	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Methotrexate—breast cancer	5.15e-05	0.000137	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—breast cancer	5.14e-05	0.000137	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—breast cancer	5.14e-05	0.000137	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Epirubicin—breast cancer	5.1e-05	0.000136	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Paclitaxel—breast cancer	5.09e-05	0.000136	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—CFL1—breast cancer	5.06e-05	0.00152	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—IDH1—breast cancer	5.05e-05	0.00152	CbGpPWpGaD
Gadobenate Dimeglumine—Back pain—Epirubicin—breast cancer	5.04e-05	0.000135	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Capecitabine—breast cancer	5.03e-05	0.000134	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—breast cancer	5.03e-05	0.000134	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Methotrexate—breast cancer	5.02e-05	0.000134	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—GRB7—breast cancer	5.02e-05	0.00151	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—breast cancer	5.01e-05	0.00151	CbGpPWpGaD
Gadobenate Dimeglumine—Muscle spasms—Epirubicin—breast cancer	5.01e-05	0.000134	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—breast cancer	5e-05	0.000134	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Capecitabine—breast cancer	4.99e-05	0.000133	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—breast cancer	4.99e-05	0.000133	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Docetaxel—breast cancer	4.99e-05	0.000133	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Docetaxel—breast cancer	4.99e-05	0.000133	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Methotrexate—breast cancer	4.99e-05	0.000133	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—breast cancer	4.97e-05	0.000133	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—breast cancer	4.95e-05	0.000132	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Paclitaxel—breast cancer	4.92e-05	0.000131	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—SYNJ2—breast cancer	4.9e-05	0.00147	CbGpPWpGaD
Gadobenate Dimeglumine—Cough—Methotrexate—breast cancer	4.86e-05	0.00013	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—breast cancer	4.85e-05	0.00013	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Capecitabine—breast cancer	4.85e-05	0.000129	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Epirubicin—breast cancer	4.84e-05	0.000129	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet degranulation—TGFB1—breast cancer	4.83e-05	0.00145	CbGpPWpGaD
Gadobenate Dimeglumine—Body temperature increased—Capecitabine—breast cancer	4.83e-05	0.000129	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Capecitabine—breast cancer	4.83e-05	0.000129	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—breast cancer	4.82e-05	0.000129	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—breast cancer	4.82e-05	0.000129	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Epirubicin—breast cancer	4.82e-05	0.000129	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—TUBB3—breast cancer	4.75e-05	0.00143	CbGpPWpGaD
Gadobenate Dimeglumine—Chest pain—Methotrexate—breast cancer	4.74e-05	0.000127	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Methotrexate—breast cancer	4.74e-05	0.000127	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Methotrexate—breast cancer	4.74e-05	0.000127	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—VEGFC—breast cancer	4.74e-05	0.00142	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—ALDOA—breast cancer	4.74e-05	0.00142	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Paclitaxel—breast cancer	4.73e-05	0.000126	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—breast cancer	4.72e-05	0.000126	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.71e-05	0.000126	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Epirubicin—breast cancer	4.7e-05	0.000125	CcSEcCtD
Gadobenate Dimeglumine—Rash—Paclitaxel—breast cancer	4.69e-05	0.000125	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Paclitaxel—breast cancer	4.69e-05	0.000125	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Methotrexate—breast cancer	4.68e-05	0.000125	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Epirubicin—breast cancer	4.67e-05	0.000125	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Epirubicin—breast cancer	4.67e-05	0.000124	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—breast cancer	4.66e-05	0.000124	CcSEcCtD
Gadobenate Dimeglumine—Headache—Paclitaxel—breast cancer	4.66e-05	0.000124	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Docetaxel—breast cancer	4.65e-05	0.000124	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—TP53—breast cancer	4.64e-05	0.00139	CbGpPWpGaD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—breast cancer	4.64e-05	0.000124	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Epirubicin—breast cancer	4.61e-05	0.000123	CcSEcCtD
Gadobenate Dimeglumine—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—breast cancer	4.6e-05	0.00138	CbGpPWpGaD
Gadobenate Dimeglumine—Confusional state—Methotrexate—breast cancer	4.58e-05	0.000122	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Epirubicin—breast cancer	4.58e-05	0.000122	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—NDUFS3—breast cancer	4.56e-05	0.00137	CbGpPWpGaD
Gadobenate Dimeglumine—Cough—Epirubicin—breast cancer	4.55e-05	0.000121	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Methotrexate—breast cancer	4.55e-05	0.000121	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Docetaxel—breast cancer	4.52e-05	0.000121	CcSEcCtD
Gadobenate Dimeglumine—Infection—Methotrexate—breast cancer	4.52e-05	0.00012	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Epirubicin—breast cancer	4.5e-05	0.00012	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Capecitabine—breast cancer	4.5e-05	0.00012	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—breast cancer	4.47e-05	0.000119	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Docetaxel—breast cancer	4.46e-05	0.000119	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Methotrexate—breast cancer	4.46e-05	0.000119	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—breast cancer	4.46e-05	0.000119	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Epirubicin—breast cancer	4.44e-05	0.000118	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Epirubicin—breast cancer	4.44e-05	0.000118	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Epirubicin—breast cancer	4.44e-05	0.000118	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Epirubicin—breast cancer	4.42e-05	0.000118	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Paclitaxel—breast cancer	4.42e-05	0.000118	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Methotrexate—breast cancer	4.41e-05	0.000118	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.41e-05	0.000118	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Methotrexate—breast cancer	4.39e-05	0.000117	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Epirubicin—breast cancer	4.38e-05	0.000117	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Capecitabine—breast cancer	4.38e-05	0.000117	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—MED12—breast cancer	4.38e-05	0.00132	CbGpPWpGaD
Gadobenate Dimeglumine—Malaise—Doxorubicin—breast cancer	4.35e-05	0.000116	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Epirubicin—breast cancer	4.34e-05	0.000116	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—breast cancer	4.32e-05	0.000115	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Capecitabine—breast cancer	4.32e-05	0.000115	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—breast cancer	4.32e-05	0.000115	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Docetaxel—breast cancer	4.31e-05	0.000115	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Epirubicin—breast cancer	4.29e-05	0.000114	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—CHST9—breast cancer	4.28e-05	0.00129	CbGpPWpGaD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—breast cancer	4.26e-05	0.000114	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Epirubicin—breast cancer	4.25e-05	0.000114	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Methotrexate—breast cancer	4.25e-05	0.000113	CcSEcCtD
Gadobenate Dimeglumine—ALB—Folate Metabolism—IL6—breast cancer	4.25e-05	0.00128	CbGpPWpGaD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—breast cancer	4.24e-05	0.000113	CcSEcCtD
Gadobenate Dimeglumine—Infection—Epirubicin—breast cancer	4.23e-05	0.000113	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—breast cancer	4.21e-05	0.000112	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	4.19e-05	0.00126	CbGpPWpGaD
Gadobenate Dimeglumine—Shock—Epirubicin—breast cancer	4.18e-05	0.000112	CcSEcCtD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—TNF—breast cancer	4.18e-05	0.00126	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Capecitabine—breast cancer	4.18e-05	0.000111	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Epirubicin—breast cancer	4.17e-05	0.000111	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Docetaxel—breast cancer	4.17e-05	0.000111	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—breast cancer	4.16e-05	0.000111	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Epirubicin—breast cancer	4.15e-05	0.000111	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Methotrexate—breast cancer	4.14e-05	0.000111	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Epirubicin—breast cancer	4.13e-05	0.00011	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Epirubicin—breast cancer	4.11e-05	0.00011	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—breast cancer	4.11e-05	0.00011	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—breast cancer	4.11e-05	0.00011	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—breast cancer	4.11e-05	0.00011	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—breast cancer	4.09e-05	0.000109	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Methotrexate—breast cancer	4.08e-05	0.000109	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—FN1—breast cancer	4.08e-05	0.00123	CbGpPWpGaD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	4.08e-05	0.000109	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	4.07e-05	0.00122	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—COX11—breast cancer	4.06e-05	0.00122	CbGpPWpGaD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—breast cancer	4.06e-05	0.000108	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Methotrexate—breast cancer	4.05e-05	0.000108	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Methotrexate—breast cancer	4.04e-05	0.000108	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Capecitabine—breast cancer	4.04e-05	0.000108	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—breast cancer	4.02e-05	0.000107	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Docetaxel—breast cancer	4.01e-05	0.000107	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Methotrexate—breast cancer	4e-05	0.000107	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	3.99e-05	0.0012	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—TGFB2—breast cancer	3.99e-05	0.0012	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Docetaxel—breast cancer	3.98e-05	0.000106	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Epirubicin—breast cancer	3.97e-05	0.000106	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Docetaxel—breast cancer	3.97e-05	0.000106	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—breast cancer	3.97e-05	0.000106	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—THBS1—breast cancer	3.97e-05	0.00119	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC2A2—breast cancer	3.95e-05	0.00119	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Docetaxel—breast cancer	3.95e-05	0.000105	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—breast cancer	3.94e-05	0.000105	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Methotrexate—breast cancer	3.92e-05	0.000105	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Methotrexate—breast cancer	3.92e-05	0.000105	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—breast cancer	3.91e-05	0.000104	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—GATA3—breast cancer	3.91e-05	0.00117	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PIK3CG—breast cancer	3.9e-05	0.00117	CbGpPWpGaD
Gadobenate Dimeglumine—Pain—Methotrexate—breast cancer	3.89e-05	0.000104	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Capecitabine—breast cancer	3.88e-05	0.000104	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Epirubicin—breast cancer	3.88e-05	0.000103	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—ACHE—breast cancer	3.87e-05	0.00116	CbGpPWpGaD
Gadobenate Dimeglumine—Shock—Doxorubicin—breast cancer	3.87e-05	0.000103	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCG2—breast cancer	3.87e-05	0.00116	CbGpPWpGaD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—breast cancer	3.86e-05	0.000103	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—EGF—breast cancer	3.86e-05	0.00116	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Capecitabine—breast cancer	3.85e-05	0.000103	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Capecitabine—breast cancer	3.85e-05	0.000103	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—breast cancer	3.84e-05	0.000103	CcSEcCtD
Gadobenate Dimeglumine—Headache—Capecitabine—breast cancer	3.82e-05	0.000102	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—breast cancer	3.82e-05	0.000102	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Epirubicin—breast cancer	3.82e-05	0.000102	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—breast cancer	3.8e-05	0.000102	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Epirubicin—breast cancer	3.79e-05	0.000101	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Epirubicin—breast cancer	3.78e-05	0.000101	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Docetaxel—breast cancer	3.75e-05	0.0001	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Methotrexate—breast cancer	3.75e-05	9.99e-05	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Epirubicin—breast cancer	3.74e-05	9.99e-05	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Methotrexate—breast cancer	3.72e-05	9.92e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—SHMT1—breast cancer	3.71e-05	0.00112	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CDA—breast cancer	3.71e-05	0.00112	CbGpPWpGaD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—breast cancer	3.68e-05	9.81e-05	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Epirubicin—breast cancer	3.67e-05	9.8e-05	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Epirubicin—breast cancer	3.67e-05	9.79e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	3.67e-05	0.0011	CbGpPWpGaD
Gadobenate Dimeglumine—Pain—Epirubicin—breast cancer	3.64e-05	9.71e-05	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Epirubicin—breast cancer	3.64e-05	9.71e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	3.63e-05	0.00109	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Capecitabine—breast cancer	3.63e-05	9.68e-05	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Methotrexate—breast cancer	3.61e-05	9.64e-05	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Methotrexate—breast cancer	3.59e-05	9.59e-05	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Methotrexate—breast cancer	3.59e-05	9.59e-05	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.59e-05	9.57e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—SLC2A5—breast cancer	3.57e-05	0.00107	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLCO1B1—breast cancer	3.57e-05	0.00107	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—IGF1—breast cancer	3.57e-05	0.00107	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—AKT2—breast cancer	3.57e-05	0.00107	CbGpPWpGaD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—breast cancer	3.53e-05	9.43e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—IFNB1—breast cancer	3.51e-05	0.00105	CbGpPWpGaD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—breast cancer	3.51e-05	9.36e-05	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Epirubicin—breast cancer	3.51e-05	9.35e-05	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—breast cancer	3.5e-05	9.34e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	3.49e-05	0.00105	CbGpPWpGaD
Gadobenate Dimeglumine—Gastrointestinal pain—Epirubicin—breast cancer	3.48e-05	9.28e-05	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—breast cancer	3.46e-05	9.24e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—APRT—breast cancer	3.45e-05	0.00104	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—TFRC—breast cancer	3.45e-05	0.00104	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PIK3CD—breast cancer	3.43e-05	0.00103	CbGpPWpGaD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—breast cancer	3.4e-05	9.07e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—SERPINE1—breast cancer	3.39e-05	0.00102	CbGpPWpGaD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—breast cancer	3.39e-05	9.05e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—FASN—breast cancer	3.39e-05	0.00102	CbGpPWpGaD
Gadobenate Dimeglumine—Urticaria—Epirubicin—breast cancer	3.38e-05	9.02e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—BCHE—breast cancer	3.37e-05	0.00101	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Selenium Micronutrient Network—IL6—breast cancer	3.37e-05	0.00101	CbGpPWpGaD
Gadobenate Dimeglumine—Constipation—Doxorubicin—breast cancer	3.37e-05	8.98e-05	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—breast cancer	3.37e-05	8.98e-05	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Epirubicin—breast cancer	3.36e-05	8.97e-05	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Epirubicin—breast cancer	3.36e-05	8.97e-05	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Methotrexate—breast cancer	3.35e-05	8.94e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—NCOA2—breast cancer	3.32e-05	0.000998	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Methotrexate—breast cancer	3.26e-05	8.7e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—ANGPTL4—breast cancer	3.25e-05	0.000975	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ESRRA—breast cancer	3.25e-05	0.000975	CbGpPWpGaD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—breast cancer	3.24e-05	8.65e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—PLAUR—breast cancer	3.22e-05	0.000969	CbGpPWpGaD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—breast cancer	3.22e-05	8.59e-05	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Methotrexate—breast cancer	3.22e-05	8.58e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC5A5—breast cancer	3.17e-05	0.000952	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLG—breast cancer	3.15e-05	0.000947	CbGpPWpGaD
Gadobenate Dimeglumine—Hypersensitivity—Epirubicin—breast cancer	3.13e-05	8.36e-05	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—breast cancer	3.13e-05	8.34e-05	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—breast cancer	3.11e-05	8.3e-05	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—breast cancer	3.11e-05	8.3e-05	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Methotrexate—breast cancer	3.11e-05	8.3e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	3.09e-05	0.000927	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GPI—breast cancer	3.08e-05	0.000924	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HADHB—breast cancer	3.08e-05	0.000924	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—RAF1—breast cancer	3.06e-05	0.00092	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—SLC2A1—breast cancer	3.06e-05	0.000919	CbGpPWpGaD
Gadobenate Dimeglumine—Asthenia—Epirubicin—breast cancer	3.05e-05	8.14e-05	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Epirubicin—breast cancer	3.01e-05	8.03e-05	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Methotrexate—breast cancer	3.01e-05	8.02e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—PDGFA—breast cancer	2.99e-05	0.000899	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PIK3CB—breast cancer	2.99e-05	0.000899	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.94e-05	0.000884	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ALDH7A1—breast cancer	2.94e-05	0.000882	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ALDH1A1—breast cancer	2.94e-05	0.000882	CbGpPWpGaD
Gadobenate Dimeglumine—Diarrhoea—Epirubicin—breast cancer	2.91e-05	7.77e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—ITPR1—breast cancer	2.9e-05	0.000872	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	2.9e-05	0.000872	CbGpPWpGaD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—breast cancer	2.9e-05	7.74e-05	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Methotrexate—breast cancer	2.89e-05	7.71e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—ABL1—breast cancer	2.88e-05	0.000866	CbGpPWpGaD
Gadobenate Dimeglumine—Rash—Methotrexate—breast cancer	2.87e-05	7.65e-05	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Methotrexate—breast cancer	2.86e-05	7.64e-05	CcSEcCtD
Gadobenate Dimeglumine—Headache—Methotrexate—breast cancer	2.85e-05	7.6e-05	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—breast cancer	2.82e-05	7.54e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—FHL2—breast cancer	2.81e-05	0.000845	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NME1—breast cancer	2.81e-05	0.000845	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—UMPS—breast cancer	2.81e-05	0.000845	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ADSL—breast cancer	2.81e-05	0.000845	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PHGDH—breast cancer	2.81e-05	0.000845	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Epirubicin—breast cancer	2.81e-05	7.51e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—NCOA1—breast cancer	2.8e-05	0.000841	CbGpPWpGaD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—breast cancer	2.78e-05	7.43e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—LDHB—breast cancer	2.76e-05	0.000829	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—BRIP1—breast cancer	2.76e-05	0.000829	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HPSE—breast cancer	2.76e-05	0.000829	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—IL2—breast cancer	2.75e-05	0.000825	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—PLG—breast cancer	2.73e-05	0.000819	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—HGF—breast cancer	2.71e-05	0.000814	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLA2G4A—breast cancer	2.71e-05	0.000814	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Epirubicin—breast cancer	2.7e-05	7.22e-05	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Methotrexate—breast cancer	2.7e-05	7.2e-05	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—breast cancer	2.69e-05	7.19e-05	CcSEcCtD
Gadobenate Dimeglumine—Rash—Epirubicin—breast cancer	2.68e-05	7.16e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Hemostasis—CSF2—breast cancer	2.68e-05	0.000805	CbGpPWpGaD
Gadobenate Dimeglumine—Dermatitis—Epirubicin—breast cancer	2.68e-05	7.15e-05	CcSEcCtD
Gadobenate Dimeglumine—Headache—Epirubicin—breast cancer	2.66e-05	7.11e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—HMMR—breast cancer	2.62e-05	0.000786	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTA3—breast cancer	2.62e-05	0.000786	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCC1—breast cancer	2.62e-05	0.000786	CbGpPWpGaD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—breast cancer	2.6e-05	6.95e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism—PPARGC1B—breast cancer	2.53e-05	0.000761	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Epirubicin—breast cancer	2.53e-05	6.74e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—HMOX1—breast cancer	2.52e-05	0.000756	CbGpPWpGaD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—breast cancer	2.5e-05	6.68e-05	CcSEcCtD
Gadobenate Dimeglumine—Rash—Doxorubicin—breast cancer	2.48e-05	6.62e-05	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—breast cancer	2.48e-05	6.62e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.47e-05	0.000741	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.47e-05	0.000741	CbGpPWpGaD
Gadobenate Dimeglumine—Headache—Doxorubicin—breast cancer	2.47e-05	6.58e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—ABCB1—breast cancer	2.42e-05	0.000726	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—SRC—breast cancer	2.4e-05	0.00072	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTA4—breast cancer	2.39e-05	0.000719	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CA9—breast cancer	2.39e-05	0.000719	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.36e-05	0.00071	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.34e-05	0.000703	CbGpPWpGaD
Gadobenate Dimeglumine—Nausea—Doxorubicin—breast cancer	2.34e-05	6.24e-05	CcSEcCtD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—VEGFA—breast cancer	2.33e-05	0.000701	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTA2—breast cancer	2.33e-05	0.0007	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GPX2—breast cancer	2.33e-05	0.0007	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—MMP1—breast cancer	2.3e-05	0.000692	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GPX4—breast cancer	2.3e-05	0.000692	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SULT1A1—breast cancer	2.3e-05	0.000692	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PLAU—breast cancer	2.26e-05	0.000679	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CDK2—breast cancer	2.26e-05	0.000679	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTA1—breast cancer	2.25e-05	0.000676	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—IDH1—breast cancer	2.25e-05	0.000676	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NAT2—breast cancer	2.22e-05	0.000668	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—CAV1—breast cancer	2.21e-05	0.000664	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—MAPK3—breast cancer	2.21e-05	0.000663	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—TGFB1—breast cancer	2.14e-05	0.000644	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—FN1—breast cancer	2.1e-05	0.000632	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—NOS2—breast cancer	2.08e-05	0.000624	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PIK3CG—breast cancer	2.01e-05	0.000604	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.01e-05	0.000604	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—EGF—breast cancer	1.99e-05	0.000597	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—MED12—breast cancer	1.95e-05	0.000586	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—DPYD—breast cancer	1.95e-05	0.000586	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ALDOA—breast cancer	1.92e-05	0.000577	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NCOA3—breast cancer	1.86e-05	0.00056	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC2A2—breast cancer	1.85e-05	0.000556	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IGF1—breast cancer	1.84e-05	0.000553	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—AKT2—breast cancer	1.84e-05	0.000553	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.83e-05	0.00055	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—PIK3CA—breast cancer	1.82e-05	0.000548	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCG2—breast cancer	1.81e-05	0.000545	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CPT1A—breast cancer	1.81e-05	0.000545	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—MTR—breast cancer	1.81e-05	0.000545	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HPGDS—breast cancer	1.78e-05	0.000534	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PIK3CD—breast cancer	1.77e-05	0.000531	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HBA1—breast cancer	1.77e-05	0.000531	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SERPINE1—breast cancer	1.75e-05	0.000526	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTT1—breast cancer	1.72e-05	0.000518	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ACHE—breast cancer	1.72e-05	0.000518	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—NOS3—breast cancer	1.67e-05	0.000502	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP17A1—breast cancer	1.63e-05	0.00049	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PTGS1—breast cancer	1.62e-05	0.000486	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ENO1—breast cancer	1.62e-05	0.000486	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.61e-05	0.000484	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP2D6—breast cancer	1.59e-05	0.000476	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—RAF1—breast cancer	1.58e-05	0.000474	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NCOA2—breast cancer	1.56e-05	0.000467	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PIK3CB—breast cancer	1.54e-05	0.000463	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—FASN—breast cancer	1.51e-05	0.000453	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—BCHE—breast cancer	1.5e-05	0.000451	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Platelet activation, signaling and aggregation—AKT1—breast cancer	1.49e-05	0.000447	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC5A5—breast cancer	1.48e-05	0.000446	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—SLC2A1—breast cancer	1.43e-05	0.000431	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NQO1—breast cancer	1.43e-05	0.000431	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—IL2—breast cancer	1.42e-05	0.000425	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.4e-05	0.000422	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP3A4—breast cancer	1.4e-05	0.00042	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.39e-05	0.000418	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP1B1—breast cancer	1.37e-05	0.000413	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Transmembrane transport of small molecules—RAF1—breast cancer	1.37e-05	0.000411	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HSP90AA1—breast cancer	1.35e-05	0.000405	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NCOA1—breast cancer	1.31e-05	0.000394	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—STK11—breast cancer	1.29e-05	0.000388	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP19A1—breast cancer	1.29e-05	0.000388	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—SRC—breast cancer	1.24e-05	0.000371	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.21e-05	0.000364	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—VEGFA—breast cancer	1.2e-05	0.000361	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—COMT—breast cancer	1.2e-05	0.000361	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTP1—breast cancer	1.2e-05	0.000359	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—HMOX1—breast cancer	1.18e-05	0.000354	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ITPR1—breast cancer	1.18e-05	0.000353	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—MAPK3—breast cancer	1.14e-05	0.000342	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ABCB1—breast cancer	1.13e-05	0.00034	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—TYMS—breast cancer	1.11e-05	0.000334	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—TGFB1—breast cancer	1.1e-05	0.000332	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GSTM1—breast cancer	1.1e-05	0.00033	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NCOR1—breast cancer	1.1e-05	0.00033	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PLA2G4A—breast cancer	1.1e-05	0.00033	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—GPX1—breast cancer	1.05e-05	0.000316	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CYP1A1—breast cancer	1.04e-05	0.000313	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—ERCC2—breast cancer	1.03e-05	0.00031	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—KRAS—breast cancer	1.02e-05	0.000307	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—MTHFR—breast cancer	9.71e-06	0.000292	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—PIK3CA—breast cancer	9.4e-06	0.000282	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—TP53—breast cancer	9.09e-06	0.000273	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—CAV1—breast cancer	8.96e-06	0.000269	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—HRAS—breast cancer	8.7e-06	0.000261	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.56e-06	0.000257	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PIK3CG—breast cancer	8.16e-06	0.000245	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Hemostasis—AKT1—breast cancer	7.68e-06	0.000231	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PIK3CD—breast cancer	7.17e-06	0.000215	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—NOS3—breast cancer	6.77e-06	0.000203	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PIK3CB—breast cancer	6.25e-06	0.000188	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PTGS2—breast cancer	6.19e-06	0.000186	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PTEN—breast cancer	5.4e-06	0.000162	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—PIK3CA—breast cancer	3.81e-06	0.000114	CbGpPWpGaD
Gadobenate Dimeglumine—ALB—Metabolism—AKT1—breast cancer	3.11e-06	9.35e-05	CbGpPWpGaD
